Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Barbara L. Asselin"'
Autor:
Lynda M. Vrooman, Traci M. Blonquist, Marian H. Harris, Kristen E. Stevenson, Andrew E. Place, Sarah K. Hunt, Jane E. O'Brien, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Peter D. Cole, Kara M. Kelly, Caroline Laverdiere, Jean-Marie Leclerc, Bruno Michon, Marshall A. Schorin, Maria Luisa Sulis, Jennifer J.G. Welch, Donna S. Neuberg, Stephen E. Sallan, Lewis B. Silverman
Publikováno v:
Blood Advances, Vol 2, Iss 12, Pp 1449-1458 (2018)
Abstract: Dana-Farber Cancer Institute (DFCI) ALL Consortium Protocol 05-001 tested a new risk stratification system in children and adolescents with newly diagnosed acute lymphoblastic leukemia (ALL). At study entry, B-ALL patients were classified a
Externí odkaz:
https://doaj.org/article/7fe5b025a97248a2bd7140b86b897665
Autor:
Thai Hoa Tran, Marian H. Harris, Jonathan V. Nguyen, Traci M. Blonquist, Kristen E. Stevenson, Eileen Stonerock, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Peter D. Cole, Kara M. Kelly, Caroline Laverdiere, Jean-Marie Leclerc, Bruno Michon, Marshall A. Schorin, Jennifer J.G. Welch, Shalini C. Reshmi, Donna S. Neuberg, Stephen E. Sallan, Mignon L. Loh, Lewis B. Silverman
Publikováno v:
Blood Advances, Vol 2, Iss 5, Pp 529-533 (2018)
Abstract: Recurrent chromosomal rearrangements carry prognostic significance in pediatric B-lineage acute lymphoblastic leukemia (B-ALL). Recent genome-wide analyses identified a high-risk B-ALL subtype characterized by a diverse spectrum of genetic
Externí odkaz:
https://doaj.org/article/44b885b31a124a5584f54b008afc7fdf
Autor:
Eric J. Chow, Sanjeev Aggarwal, David R. Doody, Richard Aplenc, Saro H. Armenian, K. Scott Baker, Smita Bhatia, Nancy Blythe, Steven D. Colan, Louis S. Constine, David R. Freyer, Lisa M. Kopp, Caroline Laverdière, Wendy M. Leisenring, Nao Sasaki, Lynda M. Vrooman, Barbara L. Asselin, Cindy L. Schwartz, Steven E. Lipshultz
Publikováno v:
Journal of Clinical Oncology. 41:2248-2257
PURPOSE For survivors of childhood cancer treated with doxorubicin, dexrazoxane is cardioprotective for at least 5 years. However, longer-term data are lacking. METHODS Within the Children's Oncology Group and the Dana Farber Cancer Institute's Child
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5aa83f6ba1b34a89ce9210ba895b8667
https://doi.org/10.1200/jco.22.02423
https://doi.org/10.1200/jco.22.02423
Autor:
David T. Teachey, Meenakshi Devidas, Brent L. Wood, Zhiguo Chen, Robert J. Hayashi, Michelle L. Hermiston, Robert D. Annett, J. Hunter Archer, Barbara L. Asselin, Keith J. August, Steve Y. Cho, Kimberly P. Dunsmore, Brian T. Fisher, Jason L. Freedman, Paul J. Galardy, Paul Harker-Murray, Terzah M. Horton, Alok I. Jaju, Allison Lam, Yoav H. Messinger, Rodney R. Miles, Maki Okada, Samir I. Patel, Eric S. Schafer, Tal Schechter, Neelam Singh, Amii C. Steele, Maria Luisa Sulis, Sarah L. Vargas, Stuart S. Winter, Charlotte Wood, Patrick Zweidler-McKay, Catherine M. Bollard, Mignon L. Loh, Stephen P. Hunger, Elizabeth A. Raetz
Publikováno v:
J Clin Oncol
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 40, iss 19
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 40, iss 19
PURPOSE To improve the outcomes of patients with T-cell acute lymphoblastic leukemia (T-ALL) and lymphoblastic lymphoma (T-LL), the proteasome inhibitor bortezomib was examined in the Children's Oncology Group phase III clinical trial AALL1231, which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ad77077f78bd85acc4f42ec987b359a
https://pubmed.ncbi.nlm.nih.gov/35271306
https://pubmed.ncbi.nlm.nih.gov/35271306
Autor:
Robert J. Hayashi, Michelle L. Hermiston, David T. Teachey, Meenakshi Devidas, Brent L. Wood, Zhiguo Chen, Robert D Annett, Barbara L Asselin, Keith J August, Steve Y Cho, Kimberly P. Dunsmore, Jason L. Freedman, Paul J. Galardy, Paul Harker-Murray, Terzah M. Horton, Alok I Jaju, Allison Lam, Yoav H. Messinger, Rodney R. Miles, Maki Okada, Samir I Patel, Eric S Schafer, Tal Schechter-Finkelstein, Kristin A. Shimano, Neelam Singh, Amii C. Steele, Maria Luisa Sulis, Sarah L Vargas, Stuart S. Winter, Charlotte Wood, Patrick A Zweidler-McKay, Mignon L. Loh, Stephen P. Hunger, Elizabeth A. Raetz, Catherine M Bollard, Carl Allen
Publikováno v:
Blood. 140:6387-6389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbbe73dd1fbf587c56eaa82c57116fa3
https://doi.org/10.1182/blood-2022-159694
https://doi.org/10.1182/blood-2022-159694
Autor:
Cindy L. Schwartz, Steven E. Lipshultz, Emma R. Lipshultz, Lynda M. Vrooman, Eric J. Chow, David R. Doody, Saro H. Armenian, Barbara L. Asselin, Louis S. Constine, David R. Freyer, K. Scott Baker, Lisa M. Kopp, Smita Bhatia
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:536-542
Background: Childhood cancer survivors are at risk for cardiovascular disease. We assessed the burden of potentially modifiable cardiometabolic risk factors (CRF) among survivors compared with population-matched controls. Methods: Survivors previousl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32f9233e426b18aae299eecf711dc5e0
https://doi.org/10.1158/1055-9965.epi-21-0360
https://doi.org/10.1158/1055-9965.epi-21-0360
Autor:
Louis S. Constine, Lisa M. Kopp, Smita Bhatia, Cindy L. Schwartz, David R. Freyer, Steven E. Lipshultz, David R. Doody, Richard Aplenc, Lynda M. Vrooman, Saro H. Armenian, K. Scott Baker, Sanjeev Aggarwal, Wendy M. Leisenring, Eric J. Chow, Barbara L. Asselin, Yuan-Shung Huang
Publikováno v:
Cancer
Background The objective of this study was to examine long-term outcomes among children newly diagnosed with cancer who were treated in dexrazoxane-containing clinical trials. Methods P9404 (acute lymphoblastic leukemia/lymphoma [ALL]), P9425 and P94
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5008997f9e69602eaac4b8affbb2e959
https://doi.org/10.1002/cncr.33974
https://doi.org/10.1002/cncr.33974
Autor:
Uma H. Athale, Stephen E. Sallan, Maneka Puligandla, Luis A. Clavell, Lewis B. Silverman, Elena J. Ladas, Kara M. Kelly, Manuela Orjuela, Caroline Laverdière, Jennifer J.G. Welch, Barbara L. Asselin, Kristen E. Stevenson, Bruno Michon, Traci M. Blonquist, Marshall A. Schorin, Jean-Marie Leclerc, Peter D. Cole
Publikováno v:
Journal of Clinical Oncology. 38:2151-2159
PURPOSE The benefits and risks of supplementation with antioxidants during cancer therapy have been a controversial area. Few studies have systematically evaluated dietary intake of antioxidants with toxicity and survival in childhood cancer. We soug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e99bb5eafcee2fa28f25a987628dafe9
https://doi.org/10.1200/jco.19.02555
https://doi.org/10.1200/jco.19.02555
Autor:
Uma H. Athale, Yael Flamand, Traci Blonquist, Kristen E. Stevenson, Menachem Spira, Barbara L. Asselin, Luis A. Clavell, Peter D. Cole, Kara M. Kelly, Caroline Laverdiere, Jean‐Marie Leclerc, Bruno Michon, Marshall A. Schorin, Jennifer J.G. Welch, Marian H. Harris, Donna S. Neuberg, Stephen E. Sallan, Lewis B. Silverman
Publikováno v:
Pediatric bloodcancerREFERENCES. 69(8)
Although thromboembolism (TE) is a serious complication in patients with acute lymphoblastic leukemia (ALL), thromboprophylaxis is not commonly used due to the inherent bleeding risk in this population. Identifying prothrombotic risk factors will hel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::415c4bcbb86ff9b8d32e676d8bb42738
https://pubmed.ncbi.nlm.nih.gov/35316569
https://pubmed.ncbi.nlm.nih.gov/35316569
Autor:
Sarah K. Hunt, Melissa A. Burns, Bruno Michon, Olga K. Weinberg, Uma H. Athale, Kristen E. Stevenson, Stephen E. Sallan, Suzanne J. Forrest, Lewis B. Silverman, Marian H. Harris, Jean-Marie Leclerc, Caroline Laverdière, Justine M. Kahn, Donna Neuberg, Barbara L. Asselin, Andrew E. Place, Yana Pikman, Kara M. Kelly, Marshall A. Schorin, Luis A. Clavell, Jennifer J.G. Welch, Maria Luisa Sulis, Lynda M. Vrooman, Jane E. O'Brien, Lisa M. Gennarini, Alejandro Gutierrez, Peter D. Cole
Publikováno v:
Pediatric Blood & Cancer. 68
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73c6ec3bf6d4614cc985a468f135d278
https://doi.org/10.1002/pbc.28885
https://doi.org/10.1002/pbc.28885